HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 232 filers reported holding HORIZON PHARMA PLC in Q3 2016. The put-call ratio across all filers is 0.30 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $2,115,000 | +45.9% | 80,019 | +7.8% | 0.00% | +50.0% |
| Q4 2018 | $1,450,000 | +1735.4% | 74,207 | +1452.8% | 0.00% | – |
| Q2 2018 | $79,000 | +1216.7% | 4,779 | +1128.5% | 0.00% | – |
| Q1 2018 | $6,000 | -82.9% | 389 | -83.9% | 0.00% | – |
| Q4 2017 | $35,000 | +2.9% | 2,413 | -10.2% | 0.00% | – |
| Q3 2017 | $34,000 | -92.5% | 2,686 | -93.0% | 0.00% | -100.0% |
| Q2 2017 | $455,000 | -78.3% | 38,257 | -73.0% | 0.00% | -85.7% |
| Q1 2017 | $2,094,000 | +7.2% | 141,755 | +17.4% | 0.01% | 0.0% |
| Q4 2016 | $1,954,000 | -10.1% | 120,714 | +0.7% | 0.01% | -12.5% |
| Q3 2016 | $2,174,000 | +9.7% | 119,914 | -0.3% | 0.01% | 0.0% |
| Q2 2016 | $1,982,000 | -3.5% | 120,329 | -2.9% | 0.01% | -11.1% |
| Q1 2016 | $2,054,000 | +376.6% | 123,937 | +522.6% | 0.01% | +350.0% |
| Q4 2015 | $431,000 | +26.4% | 19,907 | +15.9% | 0.00% | 0.0% |
| Q3 2015 | $341,000 | -15.6% | 17,183 | +47.9% | 0.00% | 0.0% |
| Q2 2015 | $404,000 | – | 11,616 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 5,959,819 | $96,430,000 | 10.71% |
| Consonance Capital Management LP | 5,793,903 | $93,745,000 | 10.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 8,956,988 | $144,924,000 | 5.96% |
| JW Asset Management, LLC | 507,075 | $8,205,000 | 5.46% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 6,682,618 | $108,125,000 | 5.23% |
| NEXTHERA CAPITAL LP | 500,000 | $8,090,000 | 4.74% |
| Lion Point Capital, LP | 1,164,414 | $18,840,000 | 4.58% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 4,503,900 | $72,873,000 | 3.52% |
| ARMISTICE CAPITAL, LLC | 650,000 | $10,517,000 | 2.49% |
| SCOPIA CAPITAL MANAGEMENT LP | 8,081,650 | $130,761,000 | 2.48% |